Trial Profile
Ph IIb Study Evaluating the Safety & Efficacy of TXA127 in the Reduction of Incidence and Severity of Thrombocytopenia in Patients Receiving Combination Gemcitabine and Platinum Therapy for Ovarian, Fallopian Tube, or Peritoneal Carcinoma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 15 Nov 2017
Price :
$35
*
At a glance
- Drugs Angiotensin-1-7 (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- Sponsors Biotest Pharmaceuticals; Tarix Pharmaceuticals
- 29 Nov 2014 New trial record